The study had two objectives: to demonstrate PF3944 could achieve continued weight loss when switching from weekly to monthly subcutaneous injections and maintain its efficacy while reducing the dosing frequency four-fold and to demonstrate PF3944 could switch to a four-fold equivalent monthly dose while maintaining a well-tolerated and favorable safety profile
In clinical research settings, this difference matters most in how each compound is measured: Tesamorelin has been studied in trials involving GH and IGF-1 level changes, while AOD-9604 research has focused specifically on lipolysis and fat oxidation markers without the same IGF-1 elevation a distinction documented in peer-reviewed pharmacology literature comparing hGH fragments to full GHRH analogs
once prescriptions are sent, pharmacies typically fulfill in 35 business days
The serum is still fresh up to 6 months after opening (with the activeness slowly depleting over time)
However, skin tone, wrinkles, and complexion improvement start within 4 to 12 weeks of consistent use
When combined, these peptides amplify each other's effects for significantly greater GH release than either alone
